TMEM97
MOLECULAR TARGETtransmembrane protein 97
TMEM97 (transmembrane protein 97) is targeted by 15 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TMEM97
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Dolutegravir | 1.61 | 4 |
| 2 | Ibogaine | 1.61 | 4 |
| 3 | N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide [Supplementary Concept] | 1.61 | 4 |
| 4 | Astemizole Antihistamine drug now withdrawn from | 1.10 | 2 |
| 5 | Dihydroergotamine | 1.10 | 2 |
| 6 | eliprodil | 1.10 | 2 |
| 7 | Pindolol | 1.10 | 2 |
| 8 | Platelet Activating Factor | 1.10 | 2 |
| 9 | Ritodrine | 1.10 | 2 |
| 10 | Ticagrelor | 1.10 | 2 |
| 11 | Tolterodine Tartrate | 1.10 | 2 |
| 12 | cbd | 0.69 | 1 |
| 13 | Sertraline | 0.69 | 1 |
| 14 | cannabidiol | 0.69 | 1 |
| 15 | Fluvoxamine | 0.69 | 1 |
About TMEM97 as a Drug Target
TMEM97 (transmembrane protein 97) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 15 compounds with documented TMEM97 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TMEM97 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.